Invitae (NYSE:NVTA) has will acquire genetic services software developer Clear Genetics for ~$50M.
Under the terms of the agreement, NVTA will pay ~$25M in cash and the rest in shares of common stock. The transaction should close in the next few days.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.